Insiders · Profile

CARDOZA GEORGE

Chief Financial Officer at SOPHiA GENETICS · President, Pharma Services at NEOGENOMICS. Filing since 26 Oct 2011. CIK 0001518734

Company
Date
Role
Action
Shares
Amount
Of holding
5 Oct 2026
Chief Financial Officer
Sold on a plan
1,592
$12.90K
0.5%
21 Sep 2026
Chief Financial Officer
Sold on a plan
774
$6.45K
0.3%
6 Jul 2026
Chief Financial Officer
Sold on a plan
1,592
$8.42K
0.5%
22 Jun 2026
Chief Financial Officer
Sold on a plan
774
$4.16K
0.2%
5 Jun 2026
Chief Financial Officer
Bought
20,000
$99.00K
6.9%
8 Apr 2026
Chief Financial Officer
Sold on a plan
1,403
$6.80K
0.5%
7 Apr 2026
Chief Financial Officer
Sold on a plan
2,413
$11.77K
0.8%
6 Apr 2026
Chief Financial Officer
Sold on a plan
2,520
$12.21K
0.8%
19 Mar 2026
Chief Financial Officer
Sold on a plan
774
$3.70K
0.4%
3 Jun 2021
President, Pharma Services
Sold, plan not stated
31,107
$1.25M
15.0%
2 Jun 2021
President, Pharma Services
Sold, plan not stated
169,230
$6.84M
44.9%
25 Nov 2020
President, Pharma Services
Sold, plan not stated
77,074
$3.51M
17.2%
24 Nov 2020
President, Pharma Services
Sold, plan not stated
52,926
$2.39M
12.5%
6 Aug 2020
President, Pharma Services
Sold, plan not stated
82,500
$3.25M
19.0%
12 Nov 2019
President, Pharma Services
Sold, plan not stated
19,444
$450.13K
5.6%
7 Nov 2019
President, Pharma Services
Sold, plan not stated
4,000
$91.20K
1.3%
6 Nov 2019
President, Pharma Services
Sold, plan not stated
51,556
$1.18M
14.5%
3 May 2019
President, Pharma Services
Sold, plan not stated
151,676
$3.46M
33.5%
11 Mar 2016
Chief Financial Officer
Sold, plan not stated
32,000
$218.56K
14.5%
26 Nov 2014
Chief Financial Officer
Sold, plan not stated
60,000
$256.77K
33.1%
9 Dec 2013
Chief Financial Officer
Sold, plan not stated
20,000
$73.20K
28.1%
2 May 2012
Chief Financial Officer
Bought
4,000
$6.64K
8.6%
26 Oct 2011
CFO
Bought
3,000
$3.63K
7.8%
23 decisions on file.